No Image Available
Description
Menactra is a vaccine designed to protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y. It works by stimulating the body's immune system to produce antibodies against these bacteria, thereby providing immunity.
Target Diseases
- Invasive diseases caused by Neisseria meningitidis serogroups A
- C
- W-135
- and Y
- including meningitis and septicemia.
Dosage Schedule
Individuals aged 2 through 55 years: A single dose.
Possible Side Effects
- Common side effects may include: Pain
- redness
- or swelling at the injection site Headache Fatigue Muscle pain Fever
Contraindications
- Menactra should not be administered to individuals who have had a severe allergic reaction (e.g.
- anaphylaxis) to any component of the vaccine or to a previous dose of a meningococcal vaccine.
Additional Information
- Menactra is part of routine immunization schedules in many countries to protect against meningococcal disease. It's especially recommended for individuals at increased risk
- such as adolescents
- college students
- military recruits
- and travelers to areas where meningococcal disease is common.
Storage Requirements
- Menactra should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). It should not be frozen.
